L. Castellanos

发表

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

D. Alonso, Y. Perera, Jeovanis Gil, 2009, Molecular Cancer Therapeutics.

Analysis of the genetic variability and immunological properties of the NlpB antigen, a novel protein identified in Neisseria meningitidis

Y. Perera, D. García, L. Betancourt, 2009 .

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

D. Gomez, D. Alonso, Y. Perera, 2011, Molecular and Cellular Biochemistry.

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

D. Alonso, O. Mendoza, Y. Perera, 2008, Molecular and Cellular Biochemistry.

Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris

V. Besada, J. Valdés, E. Lamazares, 2005, Biotechnology Letters.

Synthesis of aminocyclitols from l-quinic acid

J. Leboul, B. Quiclet-Sire, L. Castellanos, 1980 .

Comparative Proteomic Study of Mechanisms Involved in the Expression of Recombinant Monoclonal Antibody in Non Amplified NS0 Myeloma Cell Line

S. Gaskell, R. Pérez, S. Victores, 2007 .

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

D. Alonso, Y. Perera, Jeovanis Gil, 2009, Molecular Cancer Therapeutics.